| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |